Erdheim-Chester disease: a new international cohort study on phenotype, treatment, and determinants of prognosis
From The Lancet Haematology in conversation with · 13:48
Show by The Lancet Group
Professor Julien Haroche and Professor Augusto Vaglio join us this month to discuss their new international cohort study describing phenotype, treatment, and determinants of prognosis in 1174 patients with Erdheim-Chester disease. Click here to read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00247-4/fulltext The Lancet Haematology in conversation with... is part of the Lancet Group podcast offering. Editorial team: editor-in-chief Lan-Lan Smith, deputy editor Emma Cookson, and senior editor Daniela Marin Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. Find the best science for better lives at www.thelancet.com Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
More episodes of The Lancet Haematology in conversation with
More episodes
- Thalassaemia revisited: from health burden to breakthroughs
- Dr Judith Boer on lymphoblastic leukaemia in children
- Nada Hamad on inclusion and diversity in haematology
- Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care
- Eugenia Trigoso Arjona (in English) on nursing and haematological care
- Zuguo Mei and Gary Brittenham on iron deficiency
- Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria
- Raul Cordoba on haematological malignancies in older people
- Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia
- Fredrik Schjesvold on OCEAN phase 3
podsearch is a free, independent podcast search engine. Read about podsearch, the privacy policy or contact us.